These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
367 related items for PubMed ID: 30451123
1. Thiopurine Methyltransferase Genetic Polymorphisms and Activity and Metabolic Products of Azathioprine in Patients with Inflammatory Bowel Disease. Pashazadeh P, Marjani A, Asadi J, Khoshnia M. Endocr Metab Immune Disord Drug Targets; 2019; 19(4):541-547. PubMed ID: 30451123 [Abstract] [Full Text] [Related]
2. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease. Cao Q, Zhu Q, Shang Y, Gao M, Si J. Digestion; 2009; 79(1):58-63. PubMed ID: 19252404 [Abstract] [Full Text] [Related]
3. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases. Hlavaty T, Batovsky M, Balakova D, Pav I, Celec P, Gregus M, Zakuciova M, Hlista M, Horakova M, Desatova B, Koller T, Toth J, Kadasi L, Huorka M, Slovak IBD study group (SK IBD). Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552 [Abstract] [Full Text] [Related]
4. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects. Steponaitiene R, Kupcinskas J, Survilaite S, Varkalaite G, Jonaitis L, Kiudelis G, Denapiene G, Valantinas J, Skieceviciene J, Kupcinskas L. Adv Med Sci; 2016 Mar; 61(1):135-40. PubMed ID: 26674571 [Abstract] [Full Text] [Related]
9. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease? Fangbin Z, Xiang G, Minhu C, Liang D, Feng X, Min H, Pinjin H. Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442 [Abstract] [Full Text] [Related]
10. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients. Kurzawski M, Dziewanowski K, Gawrońska-Szklarz B, Domański L, Droździk M. Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099 [Abstract] [Full Text] [Related]
11. Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression. Zelinkova Z, Derijks LJ, Stokkers PC, Vogels EW, van Kampen AH, Curvers WL, Cohn D, van Deventer SJ, Hommes DW. Clin Gastroenterol Hepatol; 2006 Jan; 4(1):44-9. PubMed ID: 16431304 [Abstract] [Full Text] [Related]
12. [Frequency of serious adverse events of thiopurine treatment in normal thiopurine S-methyltransferase genotype children with inflammatory bowel disease]. Tárnok A. Orv Hetil; 2019 Feb; 160(5):179-185. PubMed ID: 30686035 [Abstract] [Full Text] [Related]
13. Adverse reactions to azathioprine cannot be predicted by thiopurine S-methyltransferase genotype in Japanese patients with inflammatory bowel disease. Takatsu N, Matsui T, Murakami Y, Ishihara H, Hisabe T, Nagahama T, Maki S, Beppu T, Takaki Y, Hirai F, Yao K. J Gastroenterol Hepatol; 2009 Jul; 24(7):1258-64. PubMed ID: 19682195 [Abstract] [Full Text] [Related]
14. Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece. Coucoutsi C, Emmanouil G, Goulielmos G, Sfakianaki O, Koutroubakis IE, Kouroumalis EA. Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1284-1289. PubMed ID: 28857898 [Abstract] [Full Text] [Related]
16. Liquid chromatography-tandem mass spectrometry analysis of erythrocyte thiopurine nucleotides and effect of thiopurine methyltransferase gene variants on these metabolites in patients receiving azathioprine/6-mercaptopurine therapy. Dervieux T, Meyer G, Barham R, Matsutani M, Barry M, Boulieu R, Neri B, Seidman E. Clin Chem; 2005 Nov; 51(11):2074-84. PubMed ID: 16166171 [Abstract] [Full Text] [Related]
17. Prevalence of mutations in thiopurine S-methyltransferase gene among Slovak IBD patients. Desatova B, Hlavaty T, Balakova D, Pav I, Celec P, Gregus M, Zakuciova M, Hlista M, Horakova M, Kadasi L, Huorka M, Batovsky M. Bratisl Lek Listy; 2013 Nov; 114(6):330-2. PubMed ID: 23731044 [Abstract] [Full Text] [Related]
18. AN EPIDEMIOLOGICAL STUDY OF THIOPURINE-METHYLTRANSFERASE VARIANTS IN A CROATIAN INFLAMMATORY BOWEL DISEASE PATIENT COHORT. Ladić A, Božina N, Borzan V, Brinar M, Vucelić B, Cuković-Cavka S. Acta Clin Croat; 2016 Mar; 55(1):16-22. PubMed ID: 27333713 [Abstract] [Full Text] [Related]
19. Thiopurine S-methyltransferase genotype and the use of thiopurines in paediatric inflammatory bowel disease Greek patients. Gazouli M, Pachoula I, Panayotou I, Mantzaris G, Syriopoulou VP, Goutas N, Vlachodimitropoulos D, Anagnou NP, Roma-Giannikou E. J Clin Pharm Ther; 2010 Feb; 35(1):93-7. PubMed ID: 20175817 [Abstract] [Full Text] [Related]
20. Successful azathioprine treatment with metabolite monitoring in a pediatric inflammatory bowel disease patient homozygous for TPMT*3C. Lee MN, Woo HI, Lee YM, Kang B, Kim JW, Choe YH, Lee SY. Yonsei Med J; 2013 Nov; 54(6):1545-9. PubMed ID: 24142665 [Abstract] [Full Text] [Related] Page: [Next] [New Search]